Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice

Experimental Physiology

Volumn 94, Issue 6, 2009, Pages 749-760

  Malek, Moh H ^a,b   Olfert, I Mark ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE; OXYGEN; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDURANCE; ENZYME ACTIVITY; EXERCISE; EXHAUSTION; GENE DELETION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HINDLIMB; MORPHOMETRICS; MOUSE; MUSCLE CAPILLARY; MUSCLE CELL; NEGATIVE FEEDBACK; NONHUMAN; OXYGEN TRANSPORT; RUNNING; SKELETAL MUSCLE; SURFACE PROPERTY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; VELOCITY; WILD TYPE;

EID: 65649095184     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2008.045989     Document Type: Article

References (55)

1. Agah A, Kyriakides TR, Lawler J Bornstein P (2002). The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 161, 831 839.
2. Augusto V, Padovani CR Rocha Campos GE (2004). Skeletal muscle fiber types in C57BL6J mice. Braz J Morphol Sci 21, 89 94.
3. Bagavandoss P Wilks JW (1990). Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 170, 867 872. (Pubitemid 20249499)
4. Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW Peterson KL (2004). The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci USA 101, 3697 3702. (Pubitemid 38338257)
5. BenEzra D, Griffin BW, Maftzir G Aharonov O (1993). Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci 34, 3601 3608. (Pubitemid 24011998)
6. Bergmeyer HU (1974). Methods in Enzymatic Analysis. Academic Press, New York.
7. Bornstein P (1992). Thrombospondins: structure and regulation of expression published erratum appears in FASEB J 1993 Jan;7(1):237 FASEB J 6, 3290 3299.
8. Carraro U Catani C (1983). A sensitive SDS-PAGE method separating myosin heavy chain isoforms of rat skeletal muscles reveals the heterogeneous nature of the embryonic myosin. Biochem Biophys Res Commun 116, 793 802. (Pubitemid 14202664)
9. Chan CK, Pham LN, Zhou J, Spee C, Ryan SJ Hinton DR (2005). Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab Invest 85, 721 733. (Pubitemid 40799702)
10. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP Bouck N (1998). Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159 1170. (Pubitemid 28307421)
11. DiPietro LA (1997). Thrombospondin as a regulator of angiogenesis. EXS 79, 295 314.
12. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM Polverini PJ (1996). Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 148, 1851 1860. (Pubitemid 26171679)
13. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J Entman ML (2005). Critical Role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111, 2935 2942. (Pubitemid 40814186)
14. Gavin TP Wagner PD (2001). Effect of short-term exercise training on angiogenic growth factor gene responses in rat. J Appl Physiol 90, 1219 1226. (Pubitemid 32220902)
15. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath AK, Huang Y, Hickey R, Dalton N, Peterson KL, Ross J Jr., Chien KR Ferrara N (2001). A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98, 5780 5785. (Pubitemid 32435719)
16. Grant SW, Kyshtoobayeva AS, Kurosaki T, Jakowatz J Fruehauf JP (1998). Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detect Prev 22, 185 194. (Pubitemid 28226749)
17. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG Cote RJ (1997). Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89, 219 227. (Pubitemid 27073759)
18. Guo N, Krutzsch H, Inman J Roberts D (1997). Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57, 1735 1742. (Pubitemid 27199668)
19. Gupta K, Gupta P, Wild R, Ramakrishnan S Hebbel RP (1999). Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 3, 147 158. (Pubitemid 129644641)
20. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, Yan Z Spiegelman BM (2007). Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J Biol Chem 282, 30014 30021. (Pubitemid 350035265)
21. Hepple RT (1997). A new measurement of tissue capillarity: the capillary-to-fibre perimeter exchange index. Can J Appl Physiol 22, 11 22. (Pubitemid 127448639)
22. Hepple RT Mathieu-Costello O (2001). Estimating the size of the capillary-to-fiber interface in skeletal muscle: a comparison of methods. J Appl Physiol 91, 2150 2156. (Pubitemid 33015068)
23. Hogg PJ (1994). Thrombospondin-1 as an enzyme inhibitor. Thromb Haemost 72, 787 792.
24. Howlett RA, Gonzalez NC, Wagner HE, Fu Z, Britton SL, Koch LG Wagner PD (2003). Genetic models in applied physiology: skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance. J Appl Physiol 94, 1682 1688. (Pubitemid 36348850)
25. Iruela-Arispe ML, Bornstein P Sage EH (1991). Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88, 5026 5030. (Pubitemid 21914676)
26. Iruela-Arispe ML, Lombardo M, Krutzsch HC, Lawler J Roberts DD (1999). Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100, 1423 1431. (Pubitemid 29451703)
27. Iruela-Arispe ML, Porter P, Bornstein P Sage EH (1995). Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97, 403 412.
28. Isenberg JS, Hyodo F, Matsumoto K-I, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC Roberts DD (2006). Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 109, 1945 1952.
29. Kivela R, Silvennoinen M, Lehti M, Jalava S, Vihko V Kainulainen H (2008). Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc Diabetol 7, 13.
30. Kivela R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H Vihko V (2006). Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J 20, 1570 1572.
31. Kohn TA Myburgh KH (2006). Electrophoretic separation of human skeletal muscle myosin heavy chain isoforms: the importance of reducing agents. J Physiol Sci 56, 355 360. (Pubitemid 46996767)
32. Lawler J (2002). Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6, 1 12. (Pubitemid 44133979)
33. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H Hynes RO (1998). Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101, 982 992. (Pubitemid 28125276)
34. Lawler J, Weinstein R Hynes O (1988). Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107, 2351 2361. (Pubitemid 19015113)
35. Lojda Z (1979). Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase). II. Blood vessels. Histochemistry 59, 153 166. (Pubitemid 9088411)
36. Mizunoya W, Wakamatsu J, Tatsumi R Ikeuchi Y (2008). Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. Anal Biochem 377, 111 113.
37. Mosher DF (1990). Physiology of thrombospondin. Annu Rev Med 41, 85 97. (Pubitemid 20121717)
38. Mrazkova O, Grim M Carlson BM (1986). Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am J Anat 177, 141 148. (Pubitemid 16010295)
39. Murphy-Ullrich JE Hook M (1989). Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 109, 1309 1319. (Pubitemid 19220109)
40. Nicosia RF Tuszynski GP (1994). Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 124, 183 193. (Pubitemid 24054620)
41. Olfert IM, Breen EC, Gavin TP Wagner PD (2006). Temporal thrombospondin-1 mRNA response in skeletal msucle exposed to acute and chronic exercise. Growth Factors 24, 253 259. (Pubitemid 46964984)
42. Perrie WT Bumford SJ (1986). Electrophoretic separation of myosin isoenzymes. Implications for the histochemical demonstration of fibre types in biopsy specimens of human skeletal muscle. J Neurol Sci 73, 89 96. (Pubitemid 16125272)
43. Porter MM, Koolage CW Lexell J (2002). Biopsy sampling requirements for the estimation of muscle capillarization. Muscle Nerve 26, 546 548.
44. Posey KL, Hankenson K, Veerisetty AC, Bornstein P, Lawler J Hecht JT (2008). Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. Am J Pathol 172, 1664 1674.
45. Rastinejad F, Polverini PJ Bouck NP (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345 355. (Pubitemid 19052652)
46. Richardson RS, Wagner H, Mudaliar SR, Saucedo E, Henry R Wagner PD (2000). Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol 279, H772 H778. (Pubitemid 30217414)
47. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y Komuro I (2007). p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444 448. (Pubitemid 46474597)
48. Snyder GK (1990). Capillarity and diffusion distances in skeletal muscles in birds. J Comp Physiol [B] 160, 583 591.
49. Srere PA (1969). Citrate synthase methods. Methods Enzymol 13, 3 11.
50. Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J Detmar M (1999). Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155, 441 452. (Pubitemid 29370394)
51. Talmadge RJ Roy RR (1993). Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75, 2337 2340. (Pubitemid 23352414)
52. Wang S, Wu Z, Sorenson CM, Lawler J Sheibani N (2003). Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev Dyn 228, 630 642. (Pubitemid 37493982)
53. Waters RE, Rotevatn S, Li P, Annex BH Yan Z (2004). Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol 287, C1342 C1348. (Pubitemid 39382893)
54. Zabrenetzky V, Harris CC, Steeg PS Roberts DD (1994). Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59, 191 195. (Pubitemid 24343361)
55. Zhang J, Ito R, Oue N, Zhu X, Kitadai Y, Yoshida K, Nakayama H Yasui W (2003). Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma. Virchows Arch 442, 563 568. (Pubitemid 36819250)